Journal of Medical Economics, Volume 15, Issue 3 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 15, Issue 3 (2012)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Volume 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original Article

Article
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries
Aurea Duran, Erik Spaepen, Mark Lamotte, Evelyn Walter, Denise Umuhire, Carlo Lucioni, Bernardete Pinheiro, Max Brosa, Lucie Kutikova, Beatriz Pujol, Simon Van Belle & Lieven Annemans
Pages: 409-418
Published online: 13 Jan 2012
AbstractforCost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries | Full Text | References | PDF (159.2 KB)
  • 778 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia
Kapil D. Sethi, Ramon Rodriguez & Babajide Olayinka
Pages: 419-423
Published online: 18 Jan 2012
AbstractforSatisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia | Full Text | References | PDF (80.2 KB) | Supplemental
  • 1149 Views
  • 66 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients
Rainel Sánchez-de la Rosa, Eliazar Sabater, Miguel Angel Casado & Rafael Arroyo
Pages: 424-433
Published online: 27 Jan 2012
AbstractforCost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients | Full Text | References | PDF (231.6 KB)
  • 913 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Bayesian cost-effectiveness analysis for censored data: an application to antiplatelet therapy
David Bin-Chia Wu, Yi-Wen Tsai & Yu-Wen Wen
Pages: 434-443
Published online: 30 Jan 2012
AbstractforBayesian cost-effectiveness analysis for censored data: an application to antiplatelet therapy | Full Text | References | PDF (397.3 KB)
  • 499 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan
Utako Shimizu, Shota Saito, Yiwei Lings, Noriaki Iino, Junichirou James Kazama & Kohei Akazawa
Pages: 444-453
Published online: 07 Feb 2012
AbstractforCost-effectiveness achieved through changing the composition of renal replacement therapy in Japan | Full Text | References | PDF (126.4 KB)
  • 619 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective
Thomas E. Delea, Jason Rotter, Matthew Taylor, David Chandiwana, Manjinder Bains, Khalid El Ouagari, Satyin Kaura & Gareth J. Morgan
Pages: 454-464
Published online: 09 Feb 2012
AbstractforCost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective | Full Text | References | PDF (1.3 MB)
  • 678 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial
N. Brereton, B. Winn & R. Akehurst
Pages: 465-472
Published online: 14 Feb 2012
AbstractforThe cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial | Full Text | References | PDF (237.9 KB)
  • 1193 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article
Indirect comparison of the effects of anti-TNF biological agents in patients with Ankylosing Spondylitis by means of a Mixed Treatment Comparison performed on efficacy data from published randomised, controlled trials
A. Migliore, S. Broccoli, E. Bizzi & B. Laganà
Pages: 473-480
Published online: 16 Feb 2012
AbstractforIndirect comparison of the effects of anti-TNF biological agents in patients with Ankylosing Spondylitis by means of a Mixed Treatment Comparison performed on efficacy data from published randomised, controlled trials | Full Text | References | PDF (148.1 KB)
  • 872 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective
Adam Lloyd, Chad S. Boomershine, Ernest H. Choy, Arthi Chandran & Gergana Zlateva
Pages: 481-492
Published online: 17 Feb 2012
AbstractforThe cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective | Full Text | References | PDF (156.1 KB)
  • 1259 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Burden of breast cancer with brain metastasis: a French national hospital database analysis
L. Benjamin, F.-E. Cotté, F. Mercier, A. Vainchtock, G. Vidal-Trécan & I. Durand-Zaleski
Pages: 493-499
Published online: 17 Feb 2012
AbstractforBurden of breast cancer with brain metastasis: a French national hospital database analysis | Full Text | References | PDF (281.6 KB)
  • 655 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost to managed care of managing pulmonary hypertension
Qayyim Said, Bradley C. Martin, Vijay N. Joish, Charles Kreilick & Stephen C. Mathai
Pages: 500-508
Published online: 22 Feb 2012
AbstractforThe cost to managed care of managing pulmonary hypertension | Full Text | References | PDF (105.3 KB)
  • 1307 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States
Rob Boer, Anjana M. Lalla & Vasily Belozeroff
Pages: 509-520
Published online: 21 Feb 2012
AbstractforCost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States | Full Text | References | PDF (230.8 KB)
  • 844 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany
Lutz Harms, Jörn-Peter Sieb, Angela E. Williams, Ryan Graham, Rita Shlaen, Volker Claus & Carmen Pfiffner
Pages: 521-530
Published online: 21 Feb 2012
AbstractforLong-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany | Full Text | References | PDF (400.3 KB)
  • 1023 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States
Haya Ascher-Svanum PhD, Nicolas M. Furiak MS, Anthony H. Lawson MA, Timothy M. Klein BS, Lee J. Smolen BS, Robert R. Conley MD & Steven D. Culler PhD
Pages: 531-547
Published online: 21 Feb 2012
AbstractforCost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States | Full Text | References | PDF (1.5 MB)
  • 1361 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access
Article
Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors
Alpesh N. Amin, Mehul Jhaveri & Jay Lin
Pages: 548-555
Published online: 22 Feb 2012
AbstractforTemporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors | Full Text | References | PDF (222.4 KB)
  • 525 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Development and Psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) Questionnaire
Hitoshi Ishii
Pages: 556-563
Published online: 23 Feb 2012
AbstractforDevelopment and Psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) Questionnaire | Full Text | References | PDF (97 KB)
  • 3540 Views
  • 50 CrossRef citations
  • 0Altmetric
Free Access
Article
Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis
William Dunlop, Reiner Uhl, Iftekhar Khan, Anna Taylor & Garry Barton
Pages: 564-575
Published online: 23 Feb 2012
AbstractforQuality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis | Full Text | References | PDF (456.4 KB)
  • 1434 Views
  • 39 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy
Alexander Diamantopoulos, Maurizio Benucci, Stefano Capri, Wolfgang Berger, Neil Wintfeld, Giovanni Giuliani & Walter Ricciardi
Pages: 576-585
Published online: 09 Mar 2012
AbstractforEconomic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy | Full Text | References | PDF (370.2 KB) | Supplemental
  • 1492 Views
  • 34 CrossRef citations
  • 0Altmetric
Free Access
Article
Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder
Bram G. Verheggen, Richard Lee, Michelle M. Lieuw On, Maarten J. Treur, Marc F. Botteman, Steven A. Kaplan & Jeffrey N. Trocio
Pages: 586-600
Published online: 24 Feb 2012
AbstractforEstimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder | Full Text | References | PDF (471.3 KB) | Supplemental
  • 684 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US
J. I. Ivanova, R. E. Bergman, H. G. Birnbaum, A. L. Phillips, M. Stewart & D. M. Meletiche
Pages: 601-609
Published online: 01 Mar 2012
AbstractforImpact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US | Full Text | References | PDF (108.3 KB)
  • 1863 Views
  • 86 CrossRef citations
  • 0Altmetric
Free Access

Erratum

Correction
Erratum
Page: 610
Published online: 29 Mar 2012
AbstractforErratum | Full Text | PDF (41 KB)
  • 344 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis
Meg Franklin et al.
Article | Published online: 27 Apr 2024
Open Access
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
Karissa Johnston et al.
Article | Published online: 27 Apr 2024
Open Access
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Jeff Schein et al.
Article | Published online: 27 Apr 2024
Open Access
Value-based payment and financing for cell and gene therapies: challenges and potential solutions
James X. Zhang et al.
Editorial | Published online: 27 Apr 2024
Open Access
View all latest articles